Creating a new chapter in small-molecule drug development
Right Structure & Value Creation
Curing
the Incurable
Cureverse creates innovative new drugs that treat the root cause of diseases, guided by our unique 'Right Structure' research philosophy. Through this, we will unlock a healthier future, turning patients' hopes into reality
Curing
the Incurable
Cureverse creates innovative new drugs that treat the root cause of diseases, guided by our unique 'Right Structure' research philosophy. Through this, we will unlock a healthier future, turning patients' hopes into reality
Cureverse focuses on developing treatments with strong efficacy and desirable drug-like properties
We discover the right structure for novel drug candidates through our small-molecule compound discovery technology. This allows us to present a new vision for treating intractable diseases such as neurodegenerative disorders, cancer, and fibrosis. We're open to diverse business models, including licensing, co-development, and technology transfer with major pharmaceutical companies, both domestically and internationally
PIPELINE
Cureverse discovers innovative small-molecule drugs through its 'Right Structure' approach
NEWS
이화여대 글로벌AI신약개발연구센터, 큐어버스와 신약개발 MOU
뉴시스
큐어버스, ‘2025년 올해의 연구소기업’ 대상 수상
더바이오
조성진 큐어버스 대표, 국민훈장 목련장 수상
한국경제
큐어버스, 삼성서울병원과 ‘대장암’ 치료용 저분자 신약 공동 개발 ‘맞손’
더바이오
[창립 20주년 특구재단, K-딥테크 ‘혁신’ 이끈다] 큐어버스
전자신문
큐어버스, 자가면역 ‘S1P1 작용제’ 美 1상 “IND 승인”
바이오스펙테이터
